Skip to main content

Wall Street's 'dean of valuation' says pot stocks are too pricey

While shares of marijuana companies may be reaching sky-high valuations, Aswath Damodaran believes "the numbers are not there" to invest confidently just yet. From his point of view, no pot stocks have provided "compelling enough stories" that make them worth buying at such high valuations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.